Ann: Agreement for CBD Nutraceuticals Entry into China Market, page-127

Haha has a crack and claims Derma isn't a 'premium brand', then gets reminded it is being sold at Harvey Nichols (a well known luxury store), then resorts back to 'does it reflect on sales and revenue' haha typical Sparkzy.

Haven't you stated numerous times before to only make decisions based off 'facts'? We don't even know how much more revenue Derma is making following the official take over and push from CannaGlobal (not including their soon-to-be relaunch). Don't get me wrong, I'm not sitting here and claiming our sales have jumped dramatically, as we will find out in the quarterly. Although, I wouldn't expect our sales to be a whole lot higher anyway due to CannaGlobal only pushing Derma from about Jan-Feb 2019 onward.

Despite what some of you claim, MGC is kicking goals. The last few announcements have been great milestones and unexpected to say the least. I think the reason the recent announcement regarding our nutraceuticals distribution deal with YuShop had such an impact on the share price, is due to:
- Our nutraceutical brand/products now gaining exposure to the Chinese market; and
- Other than the recent 'relaunch' of our MGC Nutraceuticals website/social media, this division has been quite dormant for some time. The recent announcement came as a surprise to most.

We will see how well YuShup and MGC can drive our nutraceutical sales in China. Numbers will do the talking in the end (not some anonymous poster on HC who thinks he knows it all), but nonetheless it was a great ann. After reading the following article, it appears YuShop CEO Nathan Halsey is quite interested in the CBD space:

http://yushopglobal.com/how-china-will-lead-a-20-billion-dollar-cbd-industry-by-2022/

Excited about this division, given CannaGlobal are also pushing sales on our CBD Water Soluble 'Aquiol'.

Still many announcements in the pipeline, further news on purchase orders on CannEpil and CogniCann, news on our flowers/strains (including MGC's new MXC-10 containing 35% THC, construction of Malta, the impending relaunch of Derma and (hopefully) the unveiling of CannaGlobal.

I have one family member with dementia, and another undergoing chemotherapy. While I am invested in this stock to make money in the long term, products such as CogniCann and MGC MX201 (relief for patients during chemotherapy) are of great interest to me.

If you still sit there and think MGC as a company is just one big scam then as Sparkzy would say, your IQ is questionable. They've made mistakes, most of them are new to being involved in a publicly-listed company, and the responsibilities to the market that goes with it. Personally I believe they have greatly improved and have their mind is in the right place to continue driving MGC to a big future.

As we've just seen (as for all spec stocks), only takes one good ann to get the price jumping 40%+.

Have a good long weekend everyone.